Literature DB >> 26675529

Cytoskeleton deregulation and impairment in amino acids and energy metabolism in early atherosclerosis at aortic tissue with reflection in plasma.

Marta Martin-Lorenzo1, Laura Gonzalez-Calero1, Aroa S Maroto1, Paula J Martinez1, Irene Zubiri1, Fernando de la Cuesta2, Laura Mourino-Alvarez2, Maria G Barderas2, Angeles Heredero3, Gonzalo Aldamiz-Echevarría3, Fernando Vivanco4, Gloria Alvarez-Llamas1.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death globally, being atherosclerosis the main cause. Main risk factors are known and current effort is very much dedicated to improve prevention. However, the asymptomatic and silent course of atherosclerosis hampers an accurate and individualized risk evaluation.
OBJECTIVES: Here we investigate subjacent molecular changes taking place in arterial tissue which can be ultimately translated in a measurable fingerprint in plasma.
METHODS: First, we applied a combined approach to find out main molecular alterations at protein and metabolite level in response to early atherosclerosis development in a rabbit model. A potential reflection of all these alterations observed in aortic tissue was investigated in rabbit plasma and further analyzed in a translational study in human plasma from 62 individuals.
RESULTS: Data link the structural remodeling taking place in atherosclerotic arteries in terms of loss of contractile properties and favored cellular migration, with an up-regulation of integrin linked kinase, tropomyosin isoform 2 and capping protein gelsolin-like, and a down-regulation of vinculin. A molecular response to oxidative stress is evidenced, involving changes in the glucose metabolism enzymes pyruvate kinase (PKM) and phosphoglycerate kinase (PGK), and pyruvate. Up-regulation of aspartate connects different changes observed in amino acid metabolism and, additionally, alterations in the phosphatidylcholine route of the glycerophospholipid metabolism were found.
CONCLUSIONS: A specific molecular marker panel composed by PKM, valine and pyruvate is shown here linked to cardiovascular risk.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arteries; Atherosclerosis; Cardiovascular diseases; Metabolome; Plasma

Mesh:

Substances:

Year:  2015        PMID: 26675529     DOI: 10.1016/j.bbadis.2015.12.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Construction and validation of molecular subtypes of coronary artery disease based on ferroptosis-related genes.

Authors:  Lina Ding; Fei Long; Dan An; Jing Liu; Guannan Zhang
Journal:  BMC Cardiovasc Disord       Date:  2022-06-22       Impact factor: 2.174

Review 2.  Targeting the cytoskeleton and extracellular matrix in cardiovascular disease drug discovery.

Authors:  Bohdan B Khomtchouk; Yoon Seo Lee; Maha L Khan; Patrick Sun; Deniel Mero; Michael H Davidson
Journal:  Expert Opin Drug Discov       Date:  2022-03-08       Impact factor: 7.050

3.  Urine metabolomics insight into acute kidney injury point to oxidative stress disruptions in energy generation and H2S availability.

Authors:  Marta Martin-Lorenzo; Laura Gonzalez-Calero; Angeles Ramos-Barron; Maria D Sanchez-Niño; Carlos Gomez-Alamillo; Juan Manuel García-Segura; Alberto Ortiz; Manuel Arias; Fernando Vivanco; Gloria Alvarez-Llamas
Journal:  J Mol Med (Berl)       Date:  2017-10-04       Impact factor: 4.599

4.  Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Authors:  Marta Martin-Lorenzo; Laura Gonzalez-Calero; Paula J Martinez; Montserrat Baldan-Martin; Juan Antonio Lopez; Gema Ruiz-Hurtado; Fernando de la Cuesta; Julián Segura; Jesús Vazquez; Fernando Vivanco; Maria G Barderas; Luis M Ruilope; Gloria Alvarez-Llamas
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

5.  Peripheral-blood gene expression profiling studies for coronary artery disease and its severity in Xinjiang population in China.

Authors:  Meng Liu; Shubin Jiang; Yu Ma; Jun Ma; Waseem Hassan; Jing Shang
Journal:  Lipids Health Dis       Date:  2018-07-18       Impact factor: 3.876

6.  Analysis of urinary exosomal metabolites identifies cardiovascular risk signatures with added value to urine analysis.

Authors:  Marta Agudiez; Paula J Martinez; Marta Martin-Lorenzo; Angeles Heredero; Aranzazu Santiago-Hernandez; Dolores Molero; Juan Manuel Garcia-Segura; Gonzalo Aldamiz-Echevarria; Gloria Alvarez-Llamas
Journal:  BMC Biol       Date:  2020-12-14       Impact factor: 7.431

7.  Effect of Differences in the Microbiome of Cyp17a1-Deficient Mice on Atherosclerotic Background.

Authors:  Axel Künstner; Redouane Aherrahrou; Misa Hirose; Petra Bruse; Saleh Mohamed Ibrahim; Hauke Busch; Jeanette Erdmann; Zouhair Aherrahrou
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

8.  The metabonomics study of P-selectin glycoprotein ligand-1 (PSGL-1) deficiency inhibiting the progression of atherosclerosis in LDLR-/- mice.

Authors:  Binglin Li; Xin Lu; Jia Wang; Xiaodong He; Quliang Gu; Lijing Wang; Yongxia Yang
Journal:  Int J Biol Sci       Date:  2018-01-01       Impact factor: 6.580

9.  Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations.

Authors:  Paula J Martinez; Marta Agudiez; Dolores Molero; Marta Martin-Lorenzo; Montserrat Baldan-Martin; Aranzazu Santiago-Hernandez; Juan Manuel García-Segura; Felipe Madruga; Martha Cabrera; Eva Calvo; Gema Ruiz-Hurtado; Maria G Barderas; Fernando Vivanco; Luis M Ruilope; Gloria Alvarez-Llamas
Journal:  J Mol Med (Berl)       Date:  2020-09-11       Impact factor: 4.599

Review 10.  Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes.

Authors:  Bozidarka L Zaric; Jelena N Radovanovic; Zoran Gluvic; Alan J Stewart; Magbubah Essack; Olaa Motwalli; Takashi Gojobori; Esma R Isenovic
Journal:  Front Immunol       Date:  2020-09-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.